Allianz Global Investors
Our Managers Commentary News & Media
Mutual Funds
Fund Family Overview
Price & Performance
Literature & Forms
Services
Prospectuses & Shareholder Reports
Related Products
> Closed-End Funds
> 529 Plans

ALLIANZ FUNDS PROFILE 
All data as of 02.28.10, unless otherwise indicated. 
Allianz RCM Wellness Fund A (RAGHX)
 Print
About this Fund Performance Portfolio Review & Outlook Literature
Change Class  
Fund Overview
Highlights
  • At the close of business on October 17, 2008, the Allianz RCM Biotechnology Fund was reorganized with and into the Allianz RCM Wellness Fund.
  • Focuses on the innovative and higher-than-average growth characteristics of wellness related companies and their beneficiaries
  • Fund managers employ a "bottom-up" investment process, utilizing unique GrassrootsSM Research to affirm company analysis or macroeconomic trends
  • Lead portfolio manager Michael Dauchot is a licensed physician, allowing him to bring a practical perspective to the investment process
Why Invest in this Fund
  • Actively managed institutional investment process
  • Members of portfolio management team have "real world" healthcare and wellness-related experience
  • Emphasizes some of the most innovative companies within the healthcare sector and that promote a healthy lifestyle
  • Wellness related companies offer some of the most sustainable growth rates with significant barriers to entry
At A Glance
Symbol Lookup
 
Symbol
CUSIP
A Shares
RAGHX
018919423
Objective
Seeks long-term capital appreciation

Primary Portfolio
Stocks of domestic and international companies in the healthcare industry that provide products or services that promote or aid in achieving a healthy lifestyle

Total Fund Assets (in millions)
$133.0

Inception Date
Dec 31, 1996

Dividend Frequency
At Least Annually

Maximum Sales Charge
5.50%

Net Expense Ratio
1.480%

Gross Expense Ratio
-

> Share Class Pricing

Manager
Michael Dauchot

Mr. Dauchot, a CFA, is Portfolio Manager of the Allianz RCM Wellness Fund. He earned his M.D. from the University of Cincinnati College of Medicine and has nine years of investment experience.

Manager
Dan Hunt

Mr. Hunt has been an analyst for RCM's Healthcare team since 2004. He received his B.A. from Stanford University, and earned his M.Sc. in International Relations from the London School of Economics and Political Science.

Manager
Ken H. Tsuboi

Ken H. Tsuboi, a CFA charter-holder, joined RCM in 1996, beginning his work on the Health Care team in 2000. Ken covers international healthcare companies, analyzing stocks for recommendation to the international portfolio management team.

Manager
Paul A. Wagner


 Mr. Wagner, a CFA, joined RCM in 2006 and is currently co-portfolio manager and research analyst in biotechnology.

Management Firm
RCM Capital Management LLC (RCM)

San Francisco, California

RCM is a truly global asset manager and a company of Allianz Global Investors. The firm operates across three continents and five time zones from six international offices- San Francisco, London, Frankfurt, Hong Kong, Tokyo and Sydney. RCM's range of investment solutions spans the market cap and style spectrum and reaches from regional and global strategies to multi-asset and structured products.



> Management Commentary

Investors should consider the investment objectives, risks, charges and expenses of this Fund carefully before investing. This and other information is contained in the Fund´s prospectus and summary prospectus, if available, which may be obtained by contacting your financial advisor, or by calling 888-877-4626. Click here for the Fund´s prospectus or summary prospectus. Please read them carefully before you invest or send money.

Effective September 4, 2008, the Allianz RCM Healthcare Fund changed its name to the Allianz RCM Wellness Fund.

 

This Fund may invest at least 80% of its assets securities of wellness-related companies. This Fund may also invest in foreign securities, up to 15% in emerging market companies, IPOs, and smaller companies. Investing in foreign securities may entail risk due to foreign economic and political developments; this risk may be enhanced when investing in emerging markets. IPOs are subject to risk in that the securities have no trading history and the price may be volatile. Investments in smaller companies may be more volatile than investments in larger companies. This Fund may use derivative instruments for hedging purposes or as part of its investment strategy. Use of these instruments may involve certain costs and risks such as liquidity risk, interest rate risk, market risk, credit risk, management risk and the risk that a fund could not close out a position when it would be most advantageous to do so. Portfolios investing in derivatives could lose more than the principal amount invested in those instruments.

 

Past performance is no guarantee of future performance. Investment return and the principal value of an investment will fluctuate; shares may be worth more or less than original cost when redeemed.

 

This is not an offer or solicitation for the purchase or sale of any financial instrument. It is presented only to provide information on investment strategies and opportunities. The material contains the current opinions of the author, which are subject to change without notice. Statements concerning financial market trends are based on current market conditions, which will fluctuate. References to specific securities and issuers are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities.

 

This Fund may invest its assets in the healthcare sector. This Fund may also invest in non-U.S. securities, a portion in emerging market companies, IPOs, and smaller companies. Investing in non-U.S. securities may entail risk due to foreign economic and political developments; this risk may be enhanced when investing in emerging markets. IPOs are subject to risk in that the securities have no trading history and the price may be volatile. Investments in smaller companies may be more volatile than investments in larger companies.

 

This Fund may use derivative instruments for hedging purposes or as part of its investment strategy. Use of these instruments may involve certain costs and risks such as liquidity risk, interest rate risk, market risk, credit risk, management risk and the risk that a fund could not close out a position when it would be most advantageous to do so. Portfolios investing in derivatives could lose more than the principal amount invested in those instruments.

 

GrassrootsSM Research is a division of RCM. Research data used to generate GrassrootsSM Research recommendations is received from reporters and field force investigators who work as independent contractors for broker-dealers. Those broker-dealers supply research to RCM and certain of its affiliates that is paid for by commissions generated by orders executed on behalf of RCM's clients.

 

PIMCO Funds and Allianz Funds are distributed by Allianz Global Investors Distributors LLC, 1345 Avenue of the Americas, New York, NY 10105-4800, www.allianzinvestors.com 1-888-877-4626.

Investment Products: NOT FDIC INSURED | MAY LOSE VALUE | NOT BANK GUARANTEED

 

Click here to view the Fund's top ten holdings and current sector weightings.

All holdings are subject to change.

 

Click here to view the Fund's current standardized performance.
CLICK TO VIEW OUR BUSINESS CONTINUITY PLAN, PROXY POLICIES & VOTING RECORDS, OR OUR PRIVACY POLICY.
About Us         Careers         Contact Us         Help

Advisor Login